COVID-19 Registry Rhineland-Palatinate (Germany)

Completed

• Conditions: COVID
• Interventions: Other: Prospective oberservational registry

• Registration Number: NCT04335188
• Lead Sponsor: IHF GmbH - Institut für Herzinfarktforschung

Brief Summary

Documentation of all patients undergoing inpatient treatment for SARS-CoV-2 infection with regard to clinical status at admission, medical history, inpatient treatment and course of disease. The aim is to create a risk stratification of the infection on the basis of clinical data as well as therapy and disease progression of the patients. This may also contribute to a better planning of resources.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-03-31
• Study First Submitted QC: 2020-04-03
• Study Start: 2020-04-06
• Study First Posted: 2020-04-06
• Primary Completion: 2023-03-31
• Study Completion: 2023-03-31
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-04
• Last Update Posted: 2023-05-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2589

Inclusion Criteria

• In-patients fulfilling the following criteria:

SARS-CoV-2 infection In-patient treatment Written informed consent for participation in observational study

Exclusion Criteria

• No explicit medical exclusion criteria are stated to avoid selection bias.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
In-patients with SARS-CoV-2 infection	Prospective oberservational registry	In-patients fulfilling the following criteria: SARS-CoV-2 infection In-patient treatment Written informed consent for participation in observational study No explicit medical exclusion criteria are stated to avoid selection bias.

Primary Outcome Measures

Name	Time	Method
Chest CT	throughout study completion, in average 1.5 years	presence of infiltrates
Chest x-ray	throughout study completion, in average 1.5 years	presence of infiltrates
Medication	throughout study completion, in average 1.5 years	number of patients with medication changes
Supportive care - ICU	throughout study completion, in average 1.5 years	number of patients with ICU treatment required
Intra-hospital complications	throughout study completion, in average 1.5 years	number of patients with complications during hospital stay
Supportive care - oxygen therapy	throughout study completion, in average 1.5 years	number of patients with oxygen therapy required
Therapeutic strategies	throughout study completion, in average 1.5 years	number of patients with ECMO required
Supportive care - ventilation	throughout study completion, in average 1.5 years	number of patients with ventilation required
Lab parameters	throughout study completion, in average 1.5 years	number of patients with significant changes in lab parameters
Vital status at discharge	throughout study completion, in average 1.5 years	vital status at discharge: alive, dead

Trial Locations

Locations (1)

Klinikum der Stadt Ludwigshafen am Rhein GmbH, Klinik für Herzchirurgie; 🇩🇪 Ludwigshafen, RLP, Germany